E-LIB Suche - Ergebnisse für: Ludwig, H.

1

P38 PATIENT-REPORTED OUTCOMES (PRO) IN RELAPSED/REFRACTORY ..:

Schjesvold, F ; Ludwig, H ; Delimpasi, S...
HemaSphere. 7 (2023) S2 - p. 32-32 , 2023

Link: https://doi.org/10.1097/..

2

EE73 Ocean (OP-103): Patients with Relapsed/Refractory Mult..:

Hellem Schjesvold, F. ; Ludwig, H. ; Delimpasi, S....
Value in Health. 26 (2023) 12 - p. S64 , 2023

Link: https://doi.org/10.1016/..

3

P08 TEMPORAL TRENDS IN PROGNOSIS OF PATIENTS WITH SMOLDERIN..:

Ludwig, H. ; Kainz, S. ; Zojer, N...
HemaSphere. 7 (2023) S2 - p. 13-14 , 2023

Link: https://doi.org/10.1097/..

4

Die Fortschritte der Physik im Jahre

[1846–1918] : 1856, Jahrgang 12 Die Fortschritte der Physik im Jahre ; 1856, Jahrgang 12

Abich, H. ; Adie, R. ; Airy, G. B.... - Reprint 2021 . , [2022]

Link: https://doi.org/10.1515/..

5

Albrecht-Thaer-Archiv

Arbeiten aus den Gebieten Bodenkunde, Pflanzenernährung, A... Albrecht-Thaer-Archiv ; Band 10, Heft 1

Heymann, W. ; Kolbe, G. ; Lehne, I.... - Reprint 2022 . , [2022]

Link: https://doi.org/10.1515/..

6

COVID-19 AND MYELOMA:

Ludwig, H ; Sonneveld, P ; Boccadoro, M.
HemaSphere. 6 (2022) - p. 5-6 , 2022

Link: https://doi.org/10.1097/..

7

P873: CARFILZOMIB RESISTANCE IS ASSOCIATED WITH SIGNIFICANT..:

Schneller, A. ; Bolomsky, A. ; Zojer, N...
HemaSphere. 6 (2022) - p. 766-767 , 2022

Link: https://doi.org/10.1097/..

8

P864: CTPS1 IS A NOVEL THERAPEUTIC TARGET IN MYELOMA - SELE..:

Pfeiffer, C. ; Beer, P. ; Asnagli, H....
HemaSphere. 6 (2022) - p. 757-758 , 2022

Link: https://doi.org/10.1097/..

9

S179: RANDOMIZED COMPARISON BETWEEN KRD AND KTD INDUCTION, ..:

Ludwig, H. ; Melchardt, T. ; Sormann, S....
HemaSphere. 6 (2022) - p. 80-81 , 2022

Link: https://doi.org/10.1097/..

10

Neurochemical and neuroinflammatory perturbations in two Gu..:

Carpenter, J.M. ; Gordon, H.E. ; Ludwig, H.D....
NeuroToxicology. 77 (2020) - p. 40-50 , 2020

Link: https://doi.org/10.1016/..

11

Prevention, monitoring and treatment of cardiovascular adve..:

Bringhen, S. ; Milan, A. ; D'Agostino, M....
Journal of Internal Medicine. 286 (2019) 1 - p. 63-74 , 2019

Link: https://doi.org/10.1111/..

12

Beteiligung und Verdienst von Koautoren – vom Forschungsber..:

Ludwig, H.
Der Gynäkologe. 51 (2018) 10 - p. 910-914 , 2018

Link: https://doi.org/10.1007/..

13

Diagnosis, treatment, and response assessment in solitary p..:

Caers, J. ; Paiva, B. ; Zamagni, E....
Journal of Hematology & Oncology. 11 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

14

Prevention and management of adverse events of Novel agents..:

Ludwig, H ; Delforge, M ; Facon, T...
Leukemia. , 2017

Link: https://doi.org/10.1038/..

15

Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexa..:

Dimopoulos, M A ; Stewart, A K ; Masszi, T...
Blood Cancer Journal. 7 (2017) 4 - p. e554-e554 , 2017

Link: https://doi.org/10.1038/..